Publication | Closed Access
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity
100
Citations
21
References
2011
Year
In patients with morbid obesity, the diagnostic performances of the FibroTest, SteatoTest, and ActiTest were statistically significant, thereby possibly reducing the need for biopsy in this population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1